GB Sciences files patents for myrcene─containing complex mixtures with US PTO to treat chronic pain and heart disorders

GB Sciences, Inc. has filed non─provisional patent applications with US to protect its myrcene─containing complex mixtures (MCCC) for the treatment of chronic pain and heart disorders.

More From BioPortfolio on "GB Sciences files patents for myrcene─containing complex mixtures with US PTO to treat chronic pain and heart disorders"